Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
162.6 USD | -0.11% | -0.06% | +4.89% |
09:57am | Medincell: listing suspended pending a press release | CF |
Apr. 30 | Alvotech to Make Humira Biosimilar Adalimumab-ryvk for Quallent | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+4.89% | 287B | |
+33.43% | 700B | |
+27.70% | 569B | |
-5.12% | 358B | |
+19.59% | 330B | |
+16.25% | 236B | |
+6.67% | 202B | |
-8.96% | 197B | |
+4.26% | 161B | |
-3.54% | 157B |
- Stock Market
- Equities
- ABBV Stock
- News AbbVie Inc.
- BMO Capital Adjusts Price Target on AbbVie to $195 From $187, Maintains Outperform Rating